RGNT · Regentis Biomaterials Ltd.
Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
|
2026-07-31
Scheduled
FINRA publishes Aug 11
|
— | — | — | — |
| 2026-07-15 | 80,592 | 143,052 | -62,460 | 1.00 |
| 2026-06-30 | 143,052 | 942,551 | -799,499 | 1.00 |
| 2026-06-15 | 942,551 | 25,580 | +916,971 | 1.00 |
| 2026-05-29 | 25,580 | 16,489 | +9,091 | 1.00 |
| 2026-05-15 | 16,489 | 12,485 | +4,004 | 1.27 |
| 2026-04-30 | 12,485 | 12,925 | -440 | 2.97 |
| 2026-04-15 | 12,925 | 14,765 | -1,840 | 3.86 |
| 2026-03-31 | 14,765 | 23,055 | -8,290 | 2.41 |
| 2026-03-13 | 23,055 | 26,985 | -3,930 | 4.72 |
| 2026-02-27 | 26,985 | 19,319 | +7,666 | 3.73 |
| 2026-02-13 | 19,319 | 14,356 | +4,963 | 1.75 |
| 2026-01-30 | 14,356 | 1,237 | +13,119 | 1.00 |
| 2026-01-15 | 1,237 | 2,638 | -1,401 | 1.00 |
| 2025-12-31 | 2,638 | 2,659 | -21 | 1.00 |
| 2025-12-15 | 2,659 | 0 | +2,659 | 1.00 |